Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1

Ítems similars

• Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations
  per: Al Assaf, Carla, et al.
  Publicat: (2015)
• JAK2 V617F, MPL W515L and JAK2 Exon 12 Mutations in Chinese Patients with Primary Myelofibrosis
  per: Xia, Jun, et al.
  Publicat: (2012)
• Familial Essential Thrombocythemia Associated with MPL W515L Mutation in Father and JAK2 V617F Mutation in Daughter
  per: Trifa, Adrian P., et al.
  Publicat: (2014)
• Prevalence of MPL (W515K/L) Mutations in Patients with Negative-JAK2 (V617F) Myeloproliferative Neoplasm in North-East of Iran
  per: Shams, Seyyede Fatemeh, et al.
  Publicat: (2018)
• A Multiplex Snapback Primer System for the Enrichment and Detection of JAK2 V617F and MPL W515L/K Mutations in Philadelphia-Negative Myeloproliferative Neoplasms
  per: Wu, Zhiyuan, et al.
  Publicat: (2014)